Bacterial Meningitis

The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against five meningococcal serogroups, the company announced.

The most recent MMWR included a report about a novel, emerging strain of beta-lactamase-producing Neisseria meningitidis in the United States that is resistant to both penicillin and ciprofloxacin.